In Brief: Sofamor Danek v. U.S. Surgical
This article was originally published in The Gray Sheet
Sofamor Danek v. U.S. Surgical: U.S. District Court in Los Angeles rules in a summary judgment that the Ray Threaded Fusion Cage, made by U.S. Surgical's Surgical Dynamics subsidiary, does not infringe a Sofamor Danek patent, USSC announces June 5. In a same-day press release, Sofamor Danek says it plans to appeal the ruling...
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.